Response of motor complications in Cockayne syndrome to carbidopa-levodopa.
BACKGROUND
Gait difficulties, tremors, and coordination difficulties are common features of Cockayne syndrome that are consequences of leukodystrophy, cerebellar atrophy, and demyelinating neuropathy, but no pharmacotherapy for these disabling symptoms is available.


OBJECTIVE
To determine whether carbidopa-levodopa relieves tremors and other motor complications of Cockayne syndrome.


METHODS
Mutation analysis and case report study.


METHODS
Hospital clinic and genetics research laboratory. Patients We studied 3 patients with Cockayne syndrome, a rare autosomal recessive neurodegenerative disorder for which no known treatments are available. Intervention Carbidopa-levodopa therapy.


METHODS
Status of tremors, ability to perform daily tasks, serial physical examinations, and results of handwriting samples.


RESULTS
All 3 patients had a clear reduction in tremors and improvements in handwriting and manipulation of utensils and cups.


CONCLUSIONS
Patients with Cockayne syndrome should be evaluated carefully for movement disorders. A clinical trial should be considered to evaluate this therapy further.
Neilan
Edward G
EG
Division ofGenetics, Children's Hospital Boston, Boston, MA 02115, USA.
Delgado
Mauricio R
MR
Donovan
Melissa A
MA
Kim
Sara Y
SY
Jou
Rita L
RL
Wu
Bai-Lin
BL
Kang
Peter B
PB
D000293:Adolescent; D002230:Carbidopa / Q000008:administration & dosage*; D003057:Cockayne Syndrome / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage*; D008297:Male; D009069:Movement Disorders / Q000150:complications / Q000188:drug therapy* / Q000235:genetics
D007980:Levodopa; D002230:Carbidopa